Non-invasive Haemodynamic Monitoring in Pregnancy

Hospital Nord55 enrolled

Overview

This prospective and observational trial over 55 pregnant women (third trimester) compares non invasive haemodynamic monitoring using Nexfin technology and ultrasonography technic

Study Type

OBSERVATIONAL

Enrollment

Conditions

Interventions

haemodynamic evaluationOTHER

continous haemodynamic monitoring is performed with digital Nexfin captor in two positions. in the same time transthoracic cardiac ultrasonography is performed to calculate cardiac output using velocity time index of aortic outflow chamber.

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 65 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * third trimester of pregnancy * Non-labouring pregnant women * accepting study Exclusion Criteria: * refusal of study * first or second trimester of pregnancy

Locations (1)

Departement anesthesie reanimation hopital nord

Marseille, France

Outcomes

Primary Outcomes

Cardiac output measure

Cardiac output is measured with non-invasive digital Nexfin technology (ml/min) and compared with transthoracic echocardiographic measure of cardiac output (ml/min) used as reference. Echographic cardiac output (ml/min) is measured as the produce of cross sectional aera of left ventricular outflow track (cm²) multiplied by velocity time index (cm) multiplied by heart rate (beat/min)

Time frame: 30 minutes

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.